Loading AdSense...

Sopharma AD

Last Update

Aug 4, 2008 00:00 CET

history

This article is locked. To get access, please log in or register.

General Information

Logo

Date Established

Jan 1, 1933

Alternative Names

Sofarma

Company Overview

Sopharma AD is Bulgaria's second-largest producer of pharmaceuticals and active substances, based in Sofia.

Contact Information

Address	16 Iliensko Shose Str. 1220 Sofia Bulgaria	E-mail
Tel	+359 2 8134 200 +359 2 9361 001
Fax	+359 2 936 02 86	URL	http://www.sopharma.bg/ http://ru.sopharma.bg

Offices

N/A

Industry Information

Main Industry	Pharmaceuticals
Major In Industry	yes
Secondary Industries

Legal Information

Major In Country	yes
Country	Bulgaria
Unique Identification Number	831902088

Stock Exchange Note

The company is listed on the Bulgarian Stock Exchange and included in SOFIX, BG40 and BGTR30 indexes, in the Vienna Stock Exchange SETX Index and CECE MID Caps Index, as well as in Dow Jones STOXX EU Enlarged Total Market Index (TMI) and Dow Jones STOXX Balkan 50 Equal Weighted Index.
Former stock symbol: SFARM

Stock Quote — 3JR

2.27
-0.00BGN -0.09%

As of Jan 7, 2009 00:00 CET

News

Elana - Company Profile - Sopharma - Sept 30, 2007

Latvia’s Olainfarm Mulls Outsourcing Ampuled Drug Production to Bulgaria’s Sopharma or Lithuania's Sanitas

more...

Deals

Bulgarian Drug Maker Sopharma Raises Stake in Ukraine's Vitamini to 99.07%

Bulgarian Drug Maker Sopharma Raises Stake in Ukraine’s Vitamini to 79.07%

more...

Company History

Management

Shareholders/Investors

Subsidiaries & Affiliated Companies

Products / Services

Capacity

Employment

Investment Plans

Company Reports

Company Brands

Company Certificates

Financial Information & Key Financial Ratios

investment projects in the Southeast Europe

Disclaimer

Whilst the information contained in this Profile has been given in good faith and every effort has been made to ensure its accuracy, AII Data Processing cannot guarantee the accuracy of this information and hereby expressly disclaims any responsibility for error, mis-interpretation and any and all loss, disappointment, negligence or damage caused by reliance on the information contained in the Profile or any failure or alleged failure in the delivery of the Service referred to herein, or in the event of bankruptcy, liquidation or cessation of trade in any company, individual or firm referred to herein. Confirmation of the information accuracy should be sought from the establishments concerned. Unless otherwise stated, the copyrights and any other rights in all material on this site are owned by AII Data Processing. Use of this Profile is provided by AII Data Processing subject to the following Terms and
Conditions:
1. Use of this Profile constitutes your acceptance of these Terms and Conditions which take effect when you first use this Profile. AII Data Processing reserves the right to change these terms and conditions at any time by posting changes online. You are responsible for reviewing regularly information posted online to obtain timely notice of such changes. Your continued use of the Profile after changes are posted constitutes your acceptance of this agreement.
2. Neither AII Data Processing nor other related parties, whilst endeavouring to provide 24/7 availability, will be held liable if for any reason the Profile is unavailable at any time.
3. Access to this Profile may be suspended temporarily or permanently and without notice.
4. Whilst AII Data Processing endeavours to ensure that the information on this site is correct and up-to-date, no warranty, express or implied, is given as to its accuracy and AII Data Processing does not accept any liability for error or omission.
5. Part of this Profile contains materials submitted to AII Data Processing by third parties. Third parties are responsible for ensuring that materials submitted for inclusion on this Profile complies with national and relevant international law. AII Data Processing can not guarantee the accuracy of this material and hereby expressly disclaims any responsibility for error, omission or inaccuracy in the material, misinterpretation and any all loss, disappointment, negligence or damage caused by reliance on the information contained in the Profile or any failure or alleged failure in the delivery of the services referred to herein, or in the event of bankruptcy, liquidation or cessation of trade of any company, individual or firm referred to herein. Confirmation of the information accuracy should be sought from the establishments concerned or from AII Data Processing upon explicit request.
6. AII Data Processing shall not be liable for any damages (including, without limitation, damages for loss of business or loss of profits) arising in contract, tort or otherwise from the use of or inability to use this Profile, or any data contained in it, or from any action or decision taken as a result of using this Profile or any such information.
7. AII Data Processing accepts no responsibility for the content of any site to which a hypertext link from this Profile exists. Such links are provided for your convenience on an “as is” and “as available” basis with no warranty, express or implied, for the information provided within them.
 8. If any of these terms should be determined to be illegal, invalid or otherwise unenforceable by reason of the laws of any state or country in which these terms are intended to be effective, then to the extent and within the jurisdiction in which that term is illegal, invalid or enforceable, it shall be severed and deleted from the clause concerned and the remaining terms and conditions shall remain in full force and effect and continue to be binding and enforceable.
 9. By accessing and reading any part of this Profile, you should have accepted these Terms in full.

Profiles

Companies

Sopharma AD

Elana - Company Profile - Sopharma - Sept 30, 2007

Latvia’s Olainfarm Mulls Outsourcing Ampuled Drug Production to Bulgaria’s Sopharma or Lithuania's Sanitas

Bulgarian Drug Maker Sopharma Raises Stake in Ukraine's Vitamini to 99.07%

Bulgarian Drug Maker Sopharma Raises Stake in Ukraine’s Vitamini to 79.07%